Drug-induced liver injury from elexacaftor/ivacaftor/tezacaftor
- PMID: 34275759
- DOI: 10.1016/j.jcf.2021.07.001
Drug-induced liver injury from elexacaftor/ivacaftor/tezacaftor
Keywords: CFTR modulator; Cystic fibrosis; Drug-induced liver injury.
Conflict of interest statement
Declaration of Competing Interest Dr. Mogayzel has received grant funding from Vertex Pharmaceuticals
Comment in
-
Defining and Treating Cystic Fibrosis Liver Disease: Some Things Old and Some Things New.J Cyst Fibros. 2022 Mar;21(2):199-201. doi: 10.1016/j.jcf.2022.03.004. J Cyst Fibros. 2022. PMID: 35337600 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
